Email this article to a friend
In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate
-
Correspondence: Andrea Savarino asavarino@medscape.com
Retrovirology 2007, 4:21 doi:10.1186/1742-4690-4-21